Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Denying transgender minors gender-affirming care, while allowing it for cisgender minors, is sex discrimination.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Finasteride is safe and effective for hair loss in transgender men, but may affect testosterone therapy.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Australia needs better dermatological guidelines for gender-diverse patients.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Most insurance companies do not cover extra gender-affirming surgeries, with coverage being low and inconsistent.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.